Stock Evaluator: OptimizeRx Corporation (OPRX)

OptimizeRx Corporation OPRX

$8.05 0.01 0.12%
September 3, 2026 9:31:05 AM EST November 10, 2021 Volume: 3,119
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Technology

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Commentary & Analysis


Financial Summary

Share Statistics OPRX Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $151.4 $218.2 25%
Shares Out (Mil) 18.8 47.8 29%
Institutional Ownership 80.0% 79.3% 49%
Float (Mil) 14.5 39.7 24%
Beta 1.05 1.22 63%
Avg Daily Volume (000s) 178 283 44%
Price Change
(52-week)
(53.2%) 46.7% 14%
Growth OPRX Industry
Median
Percentile
(All Stocks)
Sales (5yr) 20.4% 11.8% 82%
Net Income (5yr) 34.0% 2.7% 88%
EPS (5yr) 30.6% 15.5% 82
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) 24.3% (15.8%) 82%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 4 4 4
Current EPS $0.170 $0.890 $1.058
Month Ago EPS $0.246 $0.938 $1.088
# Rev Up 1 2 3
# Rev Down 1 0 0
Three Months Ago EPS $0.240 $0.917 $1.057
Year/Year Chg (525.0%) 229.6% na
Financials OPRX Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $99 $202 26%
Net Income (TTM) (Mil) $5 ($9) 43%
EPS (TTM) $0.246 ($0.600) 48%
Operating Cash Flow (TTM) (Mil) $18 ($1) 41%
Net Cash Flow (TTM) (Mil) $8 $3 54%
Long-Term Debt (Q1) (Mil) $18 $18 32%
Enterprise Value (Q1) (Mil) $160 $171 24%
Valuation OPRX Industry
Median
Percentile
(All Stocks)
P/B 1.16 1.25 27%
P/E 32.7 41.4 73%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) 1.1 2.5 48%
Ratios OPRX Industry
Median
Percentile
(All Stocks)
Gross Margin 73.2% 61.6% 83%
Net Margin 4.7% (24.1%) 47%
ROA 2.8% (21.8%) 60%
ROE 3.7% (6.7%) 41%
Liabilities to Assets 20.2% 32.1% 13%
F-Score 7 4 82%

OptimizeRx Corporation did not pass any screens on 9/2/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors